Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor in Carotid Stenting
NCT04091074Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of ticagrelor in carotid artery stenosis (2 arms), sponsored by Assiut University. Primary endpoints: Efficacy of ticagrelor vs clopidogrel and Safety of ticagrelor vs clopidogrel. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
carotid artery stenosis
Beyond the preview
Go deeper on NCT04091074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04091074.